Diabetes Care：二甲双胍能改善心血管高危的2型糖尿病患者心血管预后（SPREAD-DIMCAD研究

2012-12-25 湘杉翻译中国医学论坛报

　　12月10日，3项中国研究同时亮相《糖尿病护理》（Diabetes Care）杂志，让我们在品味研究结果的同时不禁为中国研究者喝彩。　　上海交通大学医学院附属瑞金医院宁光教授牵头的）组糖化血红蛋白（HbA1c）均明显降低。中位随访5年时，91例发生103次主要终点事件（心血管死亡、全因死亡、非致死性心肌梗死、非致死性卒中和冠脉血运重建）。意向治疗分析显示，与格列吡嗪相比，二甲双胍

　　12月10日，3项中国研究同时亮相《糖尿病护理》（Diabetes Care）杂志，让我们在品味研究结果的同时不禁为中国研究者喝彩。

　　上海交通大学医学院附属瑞金医院宁光教授牵头的）组糖化血红蛋白（HbA1c）均明显降低。中位随访5年时，91例发生103次主要终点事件（心血管死亡、全因死亡、非致死性心肌梗死、非致死性卒中和冠脉血运重建）。意向治疗分析显示，与格列吡嗪相比，二甲双胍组发生主要终点的校正风险比为0.54。

　　宁光教授在接受本报采访时介绍：降糖药在治疗糖尿病同时能否减少心血管并发症一直受到研究者关注。目前二甲双胍和磺脲类是历史最悠久、应用最广泛的降糖药。该研究旨在比较两类药物对2型糖尿病患者心血管事件的影响，其结果将为内分泌及相关领域临床工作者提供糖尿病患者心血管保护的治疗范例和有效参考。

　　新浪微博网友@郭启煜评论：① 该获益是相对格列吡嗪而言的；② 研究中格列吡嗪使用剂量较大，为指南推荐之最大剂量，不宜模仿，应谨防低血糖；③ 低血糖的危害远远大于高血糖，对心血管疾病高危人群尤甚；④ 对合并冠心病的糖尿病患者，降糖务须谨慎，安全乃第一要务，达标诚可贵，安全价更高；⑤ 单靠降糖实现心血管获益到目前还只是假说。

与二甲双胍相关的拓展阅读：

有关二甲双胍更多资讯

原始链接：
Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; on behalf of the SPREAD-DIMCAD Investigators.Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease. Diabetes Care. 2012 Dec 10

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2013-11-15 木头人513

#Diabetes#

82 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2013-03-18 ms5439512287675881

#BET#

86 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2013-09-19 ms9608593228839890

#DIA#

64 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2013-08-16 zhaozuguo

#二甲双胍能#

79 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2012-12-27 aids213

#2型糖尿病患者#

70 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2012-12-27 xue8604

#糖尿病患者#

77 0
[GetPortalCommentsPageByObjectIdResponse(id=1901039, encodeId=92e419010391d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 15 14:54:00 CST 2013, time=2013-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759232, encodeId=95a81e592326c, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon Mar 18 04:54:00 CST 2013, time=2013-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636612, encodeId=cf4116366125e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Sep 19 22:54:00 CST 2013, time=2013-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797860, encodeId=308a1e9786086, content=<a href='/topic/show?id=27262399169' target=_blank style='color:#2F92EE;'>#二甲双胍能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23991, encryptionId=27262399169, topicName=二甲双胍能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Fri Aug 16 08:54:00 CST 2013, time=2013-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1383127, encodeId=1f06138312eb5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1101, encryptionId=196a1101f7, topicName=2型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec19483, createdName=aids213, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473681, encodeId=db0914e3681ea, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1508618, encodeId=f76d1508618de, content=<a href='/topic/show?id=884c51916cd' target=_blank style='color:#2F92EE;'>#心血管预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51916, encryptionId=884c51916cd, topicName=心血管预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de8d9990502, createdName=xiaogang320, createdTime=Thu Dec 27 08:54:00 CST 2012, time=2012-12-27, status=1, ipAttribution=)]
2012-12-27 xiaogang320

#心血管预后#

63 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管

Diabetes Care：二甲双胍能改善心血管高危的2型糖尿病患者心血管预后（SPREAD-DIMCAD研究

相关资讯

科室

工具

服务